Gilead Sciences GILD
NASDAQ GILD
$169.73 -1.14 (-0.67%)
At close: Nov 11, 2026 · 4:00 PM EST

Gilead Sciences (GILD) Convertible Debt (2009 - 2011)

Updated

Gilead Sciences (GILD) posted Convertible Debt of $2.84 billion for Q4 2010, up 145.7% from $1.16 billion a year earlier and up 0.7% from the prior quarter.

Analysis

Gilead Sciences (GILD) Convertible Debt (2009 - 2011) Analysis & Trends

Since Q2 2009, Gilead Sciences has reported Convertible Debt for 6 quarters.

  • In prior years, Gilead Sciences' Convertible Debt was $1.16 billion in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -3,030,600.00 Bn
Dec 31, 2010 2.84 Bn
Sep 30, 2010 2.82 Bn
Jun 30, 2010 562.61 Mn
Mar 31, 2010 1.17 Bn
Dec 31, 2009 1.16 Bn
Sep 30, 2009 1.14 Bn
Jun 30, 2009 1.13 Bn
Mar 31, 2009 1.11 Bn
API Access

Gilead Sciences Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=GILD&period=max&api_key=YOUR_API_KEY